The future availability of more specific markers for microglial activation and neuroinflammation (63, 64, 65, 66, 67, 68, 69, 70), to be used in place of or in parallel to TSPO ligands, will substantially help the interpretation of future results in the area of neuroinflammation and depression. The gene discussed is TSPO; the disease is major depressive disorder.